Covered recipient · General Payments record
BRET A COOK
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2023
$5,860.70
- Reported across 218 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,065.05 | 35 |
| Education | $256.98 | 3 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $216.27 | 3 |
| Mirati Therapeutics, Inc. | $166.79 | 3 |
| Acerta Pharma LLC | $137.94 | 2 |
| Regeneron Healthcare Solutions, Inc. | $124.80 | 1 |
| Janssen Biotech, Inc. | $96.53 | 2 |
| Amgen Inc. | $55.17 | 3 |
| E.R. Squibb & Sons, L.L.C. | $52.55 | 2 |
| PFIZER INC. | $48.66 | 2 |
| Merck Sharp & Dohme Corporation | $44.62 | 2 |
| GENZYME CORPORATION | $36.31 | 1 |
| Incyte Corporation | $34.92 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.08 | 1 |
| Stemline Therapeutics Inc. | $30.00 | 1 |
| GlaxoSmithKline, LLC. | $28.75 | 1 |
| Pharmacyclics LLC, An AbbVie Company | $26.32 | 1 |
| Gilead Sciences, Inc. | $24.74 | 1 |
| Sumitomo Pharma America, Inc. | $23.52 | 1 |
| Kite Pharma, Inc. | $22.71 | 1 |
| Exelixis Inc. | $18.57 | 1 |
| SOBI, INC | $18.36 | 1 |
| Myriad Genetic Laboratories, Inc. | $17.32 | 1 |
| Celgene Corporation | $16.81 | 1 |
| TAIHO ONCOLOGY, INC. | $15.05 | 1 |
| EISAI INC. | $14.87 | 1 |
| Daiichi Sankyo Inc. | $13.82 | 1 |
| Rigel Pharmaceuticals, Inc. | $2.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (38)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.